Folic-K Capsules

Folate: 1667mg is 1667.0× the Tolerable Upper Intake Level (1.0mg)

Warnings & Precautions

If you are pregnant or nursing, ask a healthcare professional.

Keep out of reach of children

Contraindications This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Warnings and precautions Folic-K Capsules should only be used under the direction and supervision of a licensed medical practitioner.

Use with caution in patients that may have a medical condition, are pregnant, lactating, trying to conceive, under the age of 18, or taking other medications.

Use with caution in patients that may have a medical condition, are pregnant, lactating, trying to conceive, under the age of 18, or taking other medications.

Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.

Pregnancy and lactation Folic-K Capsules are not intended for use in pregnant or lactating patients.

Adverse reactions You should call your doctor for medical advice about serious adverse events. To report adverse side effects or to obtain product information, contact Foxland Pharmaceuticals, Inc, at 1-844-430-7499.

Keep out of the reach of children.

Tamper evident: Do not use if seal is broken or missing.

Foxland Pharmaceuticals, Inc. does not represent these product codes to be National Drug Codes (NDC). Product codes are formatted according to standard industry practice, to meet the formatting requirement by pedigree reporting and supply-chain control including pharmacies.

This product is a prescription-folate with or without other dietary ingredients that - due to increased folate levels increased risk associated with masking of B12 deficiency (pernicious anemia) requires administration under the care of a licensed medical practitioner (61 FR 8760). 1-3 The most appropriate way to ensure pedigree reporting consistent with these regulatory guidelines and safety monitoring is to dispense this product only by prescription (Rx). This is not an Orange Book product. This product may be administered only under a physician's supervision and all prescriptions using this product shall be pursuant to state statutes as applicable. The ingredients, indication or claims of this product are not to be construed to be drug claims. 1. Federal Register Notice of August 2, 1973 (38 FR 20750) 2. Federal Register Notice of October 17, 1980 (45 FR 69043, 69044) 3. Federal Register Notice of March 5, 1996 (61 FR 8760)